Skip to main content
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
19.00
+0.41 (2.21%)
At close: Mar 9, 2026, 4:00 PM EDT
18.65
-0.35 (-1.84%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Caris Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2025 FY 2024 FY 2023 FY 2022
Period Ending
 Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
5,3697,612---
Enterprise Value
4,9987,284---
Last Close Price
19.0026.98---
PS Ratio
6.619.37---
PB Ratio
9.3013.19---
P/TBV Ratio
9.6213.64---
P/FCF Ratio
80.26113.80---
P/OCF Ratio
64.5791.54---
EV/Sales Ratio
6.168.97---
EV/EBITDA Ratio
73.80107.54---
EV/EBIT Ratio
110.79161.45---
EV/FCF Ratio
74.72108.88---
Debt / Equity Ratio
0.740.74-1.53-11.041.08
Debt / EBITDA Ratio
5.455.45---
Debt / FCF Ratio
6.396.39---
Net Debt / Equity Ratio
-0.64-0.64-1.29-4.86-0.55
Net Debt / EBITDA Ratio
-5.48-5.48-1.72-0.350.52
Net Debt / FCF Ratio
-5.54-5.54-1.41-0.320.42
Asset Turnover
1.111.111.090.54-
Inventory Turnover
5.255.255.244.48-
Quick Ratio
7.167.160.931.863.29
Current Ratio
7.857.851.302.553.77
Return on Equity (ROE)
-45.37%-45.37%--293.82%-
Return on Assets (ROA)
3.84%3.84%-42.48%-35.34%-
Return on Capital Employed (ROCE)
4.50%4.50%-144.20%-100.60%-54.40%
Earnings Yield
-10.02%-0.89%---
FCF Yield
1.25%0.88%---
Buyback Yield / Dilution
-371.04%-371.04%-1.59%-4.73%-
Source: S&P Capital IQ. Standard template. Financial Sources.